
zzso is a new zzso zzso with suggested superior zzso efficacy to and fewer side effects than zzso zzso zzso (4 zzso X five zzso was compared with high-dose zzso (2 zzso X five zzso in a zzso randomized, zzso trial in 62 zzso patients undergoing strongly zzso cancer zzso Patients receiving zzso experienced significantly fewer vomiting episodes than patients receiving zzso zzso of three episodes zzso eight episodes; P less than zzso zzso was more effective in decreasing the volume of zzso than was zzso zzso of 100 zzso zzso 360 zzso P less than zzso zzso percent of the patients receiving zzso and 57% of those receiving zzso experienced side zzso zzso zzso is an effective zzso in patients receiving cancer zzso zzso is less effective and has more side effects than zzso We do not recommend the further use of zzso 

